Baxter International | Fremdkapital

Aktienkurs
20.37
Täglich Wechseln
0.01 0.05%
Monatlich
3.88%
Jährlich
-40.97%
Q1 Prognose
20.91




Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
AngioDynamics USD 5.9M 5.9M 2025-02
Artivion USD 214.87M 669K 2025-09
AtriCure USD 61.86M 0 2025-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Cooper Companies USD 2.46B 26.1M 2025-09
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Fresenius EUR 10.8B 1.49B 2025-09
Globus Medical USD 427K 254K 2025-09
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 39.44B 30M 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Masimo USD 559.1M 39.6M 2025-09
Medtronic USD 27.62B 1.45B 2025-09
Merit Medical Systems USD 734.04M 1.12M 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Smith & Nephew USD 3.3B 22M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Terumo JPY 99.9B 12M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12


Baxter International Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.